Pulmonx Corp Stock Alpha and Beta Analysis
| LUNG Stock | USD 5.69 0.14 2.40% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pulmonx Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pulmonx Corp over a specified time horizon. Remember, high Pulmonx Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pulmonx Corp's market risk premium analysis include:
Beta 0.35 | Alpha (0.04) | Risk 3.88 | Sharpe Ratio (0.02) | Expected Return (0.09) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pulmonx |
Pulmonx Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pulmonx Corp market risk premium is the additional return an investor will receive from holding Pulmonx Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pulmonx Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pulmonx Corp's performance over market.| α | -0.04 | β | 0.35 |
Pulmonx Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pulmonx Corp's Buy-and-hold return. Our buy-and-hold chart shows how Pulmonx Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pulmonx Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how Pulmonx Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pulmonx Corp shares will generate the highest return on investment. By understating and applying Pulmonx Corp stock market price indicators, traders can identify Pulmonx Corp position entry and exit signals to maximize returns.
Pulmonx Corp Return and Market Media
The median price of Pulmonx Corp for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 is 6.42 with a coefficient of variation of 6.23. The daily time series for the period is distributed with a sample standard deviation of 0.4, arithmetic mean of 6.48, and mean deviation of 0.32. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com | 11/12/2024 |
2 | Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference | 11/20/2024 |
3 | Insider Selling Pulmonx Co. Director Sells 20,000 Shares of Stock | 11/27/2024 |
4 | Disposition of 410 shares by David Lehman of Pulmonx Corp at 6.18 subject to Rule 16b-3 | 12/04/2024 |
5 | Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3 | 12/05/2024 |
6 | Pulmonxs Neutral Rating Reiterated at Citigroup - MarketBeat | 12/11/2024 |
7 | Pulmonx Co. Receives Consensus Rating of Moderate Buy from Brokerages - MarketBeat | 12/17/2024 |
8 | Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3 | 12/23/2024 |
9 | Disposition of 2326 shares by Glendon French of Pulmonx Corp at 6.53 subject to Rule 16b-3 | 01/16/2025 |
10 | Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3 | 01/17/2025 |
About Pulmonx Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pulmonx or other stocks. Alpha measures the amount that position in Pulmonx Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 7.85 | 11.97 | 10.78 | 6.07 | Days Of Inventory On Hand | 385.29 | 340.97 | 306.87 | 251.91 |
Pulmonx Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of Pulmonx Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pulmonx Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pulmonx Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pulmonx Corp. Please utilize our Beneish M Score to check the likelihood of Pulmonx Corp's management manipulating its earnings.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Pulmonx Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Pulmonx Corp Backtesting, Pulmonx Corp Valuation, Pulmonx Corp Correlation, Pulmonx Corp Hype Analysis, Pulmonx Corp Volatility, Pulmonx Corp History and analyze Pulmonx Corp Performance. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Pulmonx Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.